CD8A and neoplasm: On the other hand, tumor-infiltrated lymphocyte (TIL) analysis revealed a significant increase in CD8+ T cells in the TEXomiR group compared to TEX (P = 0.039) and PBS-treated (P = 0.0063) mice (6.2 ± 1.13 vs. 4.17 ±1.23 and 2% ±1.1) (Figures 8A,B).